Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
12.65
-0.18 (-1.40%)
At close: Jun 17, 2025, 12:06 PM
Tekla Life Sciences Investors Revenue
Tekla Life Sciences Investors reported an annual revenue of $86.69M, reflecting a 268.5% growth. For the quarter ending September 30, 2024, Tekla Life Sciences Investors generated $1.91M in revenue.
Revenue (ttm)
$86.69M
Revenue Growth
268.5%
Price / Sales Ratio
4.88
Revenue / Employee
-
Employees
undefined
Market Cap
365.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|